Wilson CS, Falk A, Williams JM, Hilmes M, et al. Use of Teplizumab to Modulate Stage 2 Type 1 Diabetes in Two Individuals With Autoimmune Polyendocrine Syndrome 1. Diabetes Care 2025 Nov 12:dc251444. doi: 10.2337/dc25-1444.
PMID: 41223156